COVID RISE DUE TO OPEN BORDER

WHO failed the world in an unforgivable way. It minimized the danger of SARS 2 transmission. It failed to give clear recommendations to the world as to how they should protect themselves.

The world, lulled by earlier success in avoiding the pandemic of previous viral outbreaks of MERS and SARS 1, trusted in their invincibility and permitted International travel to continue right at the initial outbreak of Covid - 19. That was an unforgivable mistake on the part of many world leaders.

The next mistake (and some believe it was deliberate) was declaring anti-parasitic drugs illegal. The only meds that work and have ability to wipe out the virus completely, became 'illegal'???? Instead, untested vaccines were recommended in its place. It takes at least 10y. for the vaccine to be properly tested for side effects and other potential problems. Vaccines cause virus to keep on modifying itself indefinitely. That is why we still have cold virus with us. Now we have to deal with that legacy of professional blunder. The world has become incredibly stupid.

The mu variant, also known as B.1.621, was first detected in Colombia in January 2021, according to the World Health Organization (WHO). On Aug. 30, WHO classified it as a "variant of interest," and named it mu.
Where is it? The mu variant has been detected in 39 countries, including in some large outbreaks in South America and Europe, according to the WHO. The variant has also been detected in the U.S. — a study from the University of Miami detected the variant in 9% of cases at the Jackson Memorial Health System in Miami, Live Science previously reported. Although the variant makes up less than 0.1% of all COVID-19 cases worldwide that undergo genetic sequencing, it accounts for 39% of sequenced cases in Colombia and 13% in Ecuador, and has been increasing in prevalence in these areas, the WHO report said.

The mu variant "has a constellation of mutations that indicate potential properties of immune escape," WHO officials said. Early data in lab dishes show that antibodies generated in response to COVID-19 vaccination or previous infection are less able to "neutralize," or bind to and disable, the mu variant, the report said. However, this finding still needs to be confirmed by future studies.

Do vaccines work? According to Public Health England, there is "no real-world data on vaccine effectiveness" against mu. Studies in lab dishes have found a reduction in the ability of antibodies to neutralize the mu variant that is "at least as great as that seen with the beta variant," Public Health England said. The finding "raises the possibility that [mu] may manifest similar immune escape properties" as the beta variant, the agency said. Still, at that time, "there is no indication that [mu] is out-competing delta," and it seems unlikely that mu is more transmissible than the delta variant, Live Science previously reported.
Editor's note: This page is updated regularly to include new variants and new information about existing variants.
Originally published on Live Science.'

'The lambda variant, also known as C.37, was first detected in Peru in August 2020. On June 14, the World Health Organization (WHO) designated C.37 a global variant of interest, and dubbed it lambda.
Where is it? So far, lambda has been detected in 29 countries, with high levels of spread in South American countries. In recent months, the lambda variant was detected in 81% of COVID-19 cases in Peru that underwent genetic sequencing, and 31% of cases in Chile that underwent genetic testing.

The variant has seven mutations in the virus's spike protein compared with the original strain of SARS-CoV-2 detected in Wuhan.

Why is the variant concerning? Some of these mutations have the potential to increase transmissibility of the virus or to reduce the ability of certain antibodies to neutralize, or inactivate, the virus. For example, lambda has a mutation known as F490S located in the spike protein's receptor-binding domain (RBD), where the virus first docks onto human cells. A paper published in the July issue of the journal Genomics identified F490S as a likely "vaccine escape mutation" that could both make the virus more infectious and disrupt the ability of vaccine-generated antibodies to recognize the variant.